Balancing transition and readmission: a comparative study of low-dose vs standard buprenorphine initiation for medically managed opioid withdrawal

This study aimed to compare the outcomes of low-dose initiation (LDI) versus standard-dose initiation (SDI) of buprenorphine in patients with opioid use disorder undergoing medically managed withdrawal. The findings indicated that while both approaches yielded similar inpatient outcomes, LDI was associated with significantly lower odds of readmission within one year, suggesting it may be a viable alternative in the context of increased risks associated with fentanyl.